3651 results for «315»

Filter By

3651 results

What's new in antiplatelet therapy post-PCI in 2021?

16 Dec 2021 – From GulfPCR-GIM 2021

From concrete clinical cases, discover the discussions led by our experts who wonder about the post-PCI antiplatelet treatment, and learn how to integrate evidence in daily clinical practice and to individualize DAPT strategies after PCI in 2021.

What's new in antiplatelet

Challenging STEMI and MVD scenarios

16 Dec 2021 – From GulfPCR-GIM 2021

In this session, five challenging STEMI cases are discussed so as to enable you to find out how to manage complex primary PCI in STEMI with multivessel disease (MVD).

Challenging STEMI and

Emergent transcatheter therapy

21 Nov 2021 – From PCR London Valves 2021

This series of 3 videos presented during the PCR London Valves 2021 Congress allows you to appreciate an emergent mitral ViV implantation after a recent re-do bioprosthetic AVR, a cardiogenic shock after transfemoral mitral valve reconstruction, and MitraClip for torrential mitral regurgitation with Impella CP support.

Emergent transcatheter therapy

Unusual situations in valvular interventions

21 Nov 2021 – From PCR London Valves 2021

Let's discover an electrosurgical removal of an entrapped central venous catheter, witness a coronary extra-adventitial hematoma complication of transcatheter tricuspid annuloplasty, and appreciate buddy balloon technique as bailout strategy during RVOT stent embolization, among others, in this special PCR London Valves 2021 session dedicated to unusual...

Unusual situations in valvular interventions

TAVI in bicuspid aortic valves

21 Nov 2021 – From PCR London Valves 2021

Thanks to this series of videos from PCR London Valves 2021, analyze the results of self-expandable versus balloon-expandable transcatheter valves in bicuspid aortic anatomy, study the outcomes after TAVI in bicuspid aortic valve, and much more!

TAVI in bicuspid aortic valves

Complications during PCI, guidewire entrapment and and unexpected Impella complication

16 Dec 2021 – From GulfPCR-GIM 2021

Watch this series of clinical cases- would you have made the same treatment choices to manage these complications?

- Unusual complication during an angiogram
- When wires give you troube
- Routine PCI complications: a CTO technique to the rescue
- Entrapment and fracture of coronary guidewire
- An unexpected Impella...

Complications during

STEMI and cardiogenic shock

16 Dec 2021 – From GulfPCR-GIM 2021

Thanks to the 3 presentations proposed in this session, review SCAI classification of cardiogenic shock and appraise the role of MCS in the management of STEMI with cardiogenic shock in the cathlatb.

STEMI and cardiogenic

GulfPCR-GIM 2021 Closing Ceremony

16 Dec 2021 – From GulfPCR-GIM 2021

After a retrospective of the best images of the GulfPCR-GIM 2021 Congress, attend the presentation of the best clinical case award to the 2021 winner and listen to the closing highlights that put an end to this edition.

GulfPCR-GIM 2021 Closing

Preventive PCI or medical therapy alone for atherosclerotic coronary vulnerable plaques (PREVENT)

08 Apr 2024

Ali Nazmi Calik provides his take on the results of the PREVENT trial presented at ACC.24 in Atlanta.

Ali Nazmi Calik

Author

Ali Nazmi Calik
Preventive PCI or medical therapy alone for atherosclerotic coronary vulnerable plaques

OPTIMUM: Outcomes of Percutaneous RevascularizaTIon for Management of SUrgically Ineligible Patients with Multivessel or Left Main Coronary Artery Disease

04 Nov 2021

Mirvat Alasnag reviews the OPTIMUM trial, presented by David E. Kandzari, which reports outcomes in a subset of patients who are increasingly seen in modern day catheterization laboratories. It is noteworthy that 1 in 5 patients with left main or multivessel disease are considered surgically ineligible.

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
OPTIMUM: Early Outcomes From a Prospective Registry of PCI in Patients at Prohibitive Risk for CABG

Intravascular ultrasound-guided versus angiography-guided percutaneous coronary intervention in acute coronary syndromes: The multicenter, randomized, blinded, IVUS-ACS Trial

09 Apr 2024

Marco Spagnolo and Daniele Giacoppo report the main results of the IVUS-ACS trial presented by Shao-Liang Chen, from the Nanjing First Hospital, Nanjing Medical University, Nanjing, in a Featured Clinical Research session at ACC.24 in Atlanta and simultaneously published in The Lancet.(1)

Daniele Giacoppo

Author

Daniele Giacoppo
Marco Spagnolo

Author

Marco Spagnolo
IVUS-guided vs angiography-guided PCI in acute coronary syndromes
Didn’t find what you were looking for?